Chemotherapy-induced thrombocytopenia: literature review
Abstract Chemotherapy-induced thrombocytopenia (CIT) is a common condition that frequently results in reduced chemotherapy dosages, postponed treatment, bleeding, and unfavorable oncological outcomes. At present, there is no clear suggestions for preventing or treating CIT. Thrombopoietin (TPO) repl...
Main Authors: | Ai Gao, Linlin Zhang, Diansheng Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-01-01
|
Series: | Discover Oncology |
Online Access: | https://doi.org/10.1007/s12672-023-00616-3 |
Similar Items
-
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia.
by: Gerald A Soff, et al.
Published: (2022-01-01) -
Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
by: Ai Gao, et al.
Published: (2023-07-01) -
Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer:
A Case Report and Literature Review
by: Jingjing CAI, et al.
Published: (2023-09-01) -
Two Case Reports of Type 2 Diabetes Induced by Immune Checkpoint Inhibitors
Combined with Chemotherapy
by: Ping XIAO, et al.
Published: (2022-04-01) -
Immune Checkpoint Inhibitors Related Diabetes Mellitus:
A Report of 2 Cases and Literature Review
by: Yaoyao REN, et al.
Published: (2022-01-01)